The phase 3 STEP UP trial enrolled 1407 adults aged 18 years and older with a body mass index of at least 30kg/m2 and without diabetes.

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

Registered dietitian nutritionists caring for patients with chronic kidney disease are frequently challenged to help address ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

A woman who waited for four years on an NHS waiting list for weight-loss support has said she believes she could have avoided developing type 2 diabetes if she was given help sooner. Hannah Baker, 44, ...

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.

Ozempic is a brand name semaglutide, a medication used to treat type 2 diabetes. It’s also used as an off-label use for weight loss. Wegovy is another brand name with the same a ...